In the present study, we have demonstrated that PARP inhibition with talazoparib is an effective method for radiosensitizing GBM cells and, particularly, the population of stem cells, which are renowned for their radioresistance and are at the origin of most recurrences39. The gene discussed is PARP1; the disease is glioblastoma.